4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Published in 2018 – Ann Oncol (2018); 29: 1634–1657
Authors: F. Cardoso, E. Senkus, A. Costa, E. Papadopoulos, M. Aapro, F. André, N. Harbeck, B. Aguilar Lopez, C. H. Barrios, J. Bergh, L. Biganzoli, C. B. Boers-Doets, M. J. Cardoso, L. A. Carey, J. Cortés, G. Curigliano, V. Diéras, N. S. El Saghir, A. Eniu, L. Fallowfield, P. A. Francis, K. Gelmon, S. R. D. Johnston, B. Kaufman, S. Koppikar, I. E. Krop, M. Mayer, G. Nakigudde, B. V. Offersen, S. Ohno, O. Pagani, S. Paluch-Shimon, F. Penault-Llorca, A. Prat, H. S. Rugo, G. W. Sledge, D. Spence, C. Thomssen, D. A. Vorobiof, B. Xu, L. Norton & E. P. Winer
The ESO-ESMO 4th international consensus guidelines for advanced breast cancer (ABC 4) focus on methodology, assessment guidelines and treatment recommendations for specific breast cancer subtypes including ER positive/HER2-negative (luminal) ABC, HER2-positive ABC, triple-negative ABC and male metastatic breast cancer, as well as patients with specific metastases. Supportive and palliative care recommendations are also included and a new section addresses integrative medicine.